Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation

Barbash, Israel M.; Barbanti, Marco; Webb, John G.; Nicolás, Javier Molina-Martín de; Abramowitz, Yigal; Latib, Azeem; Nguyen, Chau; Deuschl, Florian; Segev, Amit; Sideris, Konstantinos; Buccheri, Sergio; Simonato, Matheus; Rosa, Francesco Della; Tamburino, Corrado; Jilaihawi, Hasan; Miyazaki, Tadashi; Himbert, Dominique; Schofer, Niklas; Guetta, Victor; Bleiziffer, Sabine; Tchétché, Didier; Immè, Sebastiano; Makkar, Raj; Vahanian, Alec; Treede, Hendrik; Lange, Rüdiger; Colombo, Antonio; Dvir, Danny

doi:10.1093/eurheartj/ehv417

Cited by 147 publications

(139 citation statements)

References 26 publications

Supporting

Mentioning

127

Contrasting

Unclassified

Order By: Relevance

“…The reported preference of Prostar XL over Proglide use in Polish centres depends on local practice. Current conflicting reports on the safety of closure device use in TAVI suggest the need for further research in this field [19, 20]. …”

Section: Discussionmentioning

confidence: 99%

The Polish Interventional Cardiology TAVI Survey (PICTS): adoption and practice of transcatheter aortic valve implantation in Poland

Parma

Dąbrowski

Ochała

et al. 2017

pwki

View full text Add to dashboard Cite

IntroductionFew studies have assessed the development of transcatheter aortic valve implantation (TAVI) in Poland since its introduction in 2008, and data on current TAVI activity or practice are missing.AimTo assess the dynamics of TAVI adoption in Poland and to detect differences among Polish centres in TAVI practice and decision-making.Material and methodsThe Polish Interventional Cardiology TAVI Survey (PICTS) was approved by the Polish Association of Cardiovascular Interventions and presented to all 21 national TAVI centres. Between 2008 and 2015 the cumulative number of TAVI performed in Poland was 2189. The annual number of TAVI rose from 8 in 2008 to 670 in 2015 (0.21 to 17.4 implants per million inhabitants, respectively).ResultsThe median TAVI experience per centre was 80 procedures (95% CI: 38.1–154.6). In 2015 the TAVI penetration rate reached 5.12% of the estimated eligible Polish population. Inoperable and high-risk patients are treated with TAVI in all centres, with 52% of Heart Teams also qualifying medium-risk patients. The rate of transfemoral implantations increased to 83.2% of all procedures in 2015, while transapical implantations decreased to 12%. The frequency of subclavian, direct aortic or transcarotid routes in 2015 was below 3% each.ConclusionsThe PICTS survey observed a positive but slow rate of adoption of TAVI in Poland. When compared to Western European countries, our findings highlight a significant treatment gap in high or prohibitive surgical risk patients with severe aortic stenosis. Remarkable variations in TAVI practices among Polish TAVI centres warrant publication of joint national guidelines and recommendations.

show abstract

Section: Discussionmentioning

confidence: 99%

The Polish Interventional Cardiology TAVI Survey (PICTS): adoption and practice of transcatheter aortic valve implantation in Poland

Parma

Dąbrowski

Ochała

et al. 2017

pwki

View full text Add to dashboard Cite

show abstract

“…There are limited and conflicting data from studies comparing the Prostar XL and ProGlide hemostasis devices in the setting of TAVR. 55,56 Vascular closure device failure is not uncommon; its reported incidence is highly variable, ranging from 2.7% to12% and it is an independent predictor of vascular complications. 22,25,57,58 In addition to patient-specific factors cited above, an operator learning curve for device deployment may contribute.…”

Section: Preventionmentioning

confidence: 99%

Vascular complications associated with transcatheter aortic valve replacement

et al. 2017

View full text Add to dashboard Cite

Transcatheter aortic valve replacement (TAVR) is now an accepted pathway for aortic valve replacement for patients who are at prohibitive, severe and intermediate risk for traditional aortic valve surgery. However, with this rising uptrend and adaptation of this new technology, vascular complications and their management remain an Achilles heel for percutaneous aortic valve replacement. The vascular complications are an independent predictor of mortality for patients undergoing TAVR. Early recognition of these complications and appropriate management is paramount. In this article, we review the most commonly encountered vascular complications associated with currently approved TAVR devices and their optimal percutaneous management techniques.

show abstract

“…Percutaneous TF‐TAVI is a safer and less invasive approach and has become a mainstream treatment strategy in TAVI. The vascular closure device (VCD) is a necessary instrument that is used to achieve haemostasis in TF‐TAVI in this era . There are a few complications peculiar to the use of the Perclose ProGlide® suture‐mediated closure system (Abbott Vascular, Santa Clara, CA), such as dissection, acute femoral artery stenosis or occlusion, bleeding, and device failure.…”

Section: Introductionmentioning

confidence: 99%

The novel echo‐guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation

Honda

Araki

Yamawaki

et al. 2017

J Interven Cardiology

View full text Add to dashboard Cite

show abstract

Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation

Abstract: Prostar XL-based vascular closure in transfemoral TAVI procedures is associated with higher major vascular complication rates when compared with ProGlide; however, in-hospital mortality is similar with both devices.

Cited by 147 publications

References 26 publications

The Polish Interventional Cardiology TAVI Survey (PICTS): adoption and practice of transcatheter aortic valve implantation in Poland

The Polish Interventional Cardiology TAVI Survey (PICTS): adoption and practice of transcatheter aortic valve implantation in Poland

Vascular complications associated with transcatheter aortic valve replacement

The novel echo‐guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation

Contact Info

Product

Resources

About